Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Guideline
AACC provides recommendations for detecting cervical cancer
The guidance aims to update healthcare and laboratory medicine professionals about the latest advancements in this field, and to help them select the most effective cervical cancer detection strategy for their patients, AACC said.
March 6, 2023
Agendia MammaPrint UltraLow Risk gene signature recognized in updated NCCN guidelines
The MammaPrint 70-gene signature identifies patients at low or high risk of distant recurrence within five years of a breast cancer diagnosis.
February 13, 2023
Study suggests race adjustment unnecessary for alpha fetoprotein prenatal testing
Researchers recommend that a longstanding race-based adjustment to test-result values of alpha fetoprotein from a common prenatal screening should be discontinued.
February 6, 2023
OIG report outlines challenges with CDC-supported COVID-19 vaccination programs
There were challenges with "vaccine logistics, such as large minimum order sizes for vaccines, requirements for ultra-cold storage, and insufficient ancillary supplies," OIG said.
January 31, 2023
Natera announces results for NIPT in twin-pregnancy clinical study
Using single-nucleotide polymorphism technology, the test analyzes fetal DNA obtained through a blood draw from the mother.
December 7, 2022
Stop: Don't order these tests
Industry organizations have collaborated on recommendations to ensure patients receive the right testing at the right time.
November 8, 2022
Most Popular
Quest launches long-COVID testing panels for consumers
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
FDA proposes updates to breakthrough devices guidance focused on reducing disparities in healthcare
The agency is proposing updates to clarify considerations in designating devices, including eligible devices that may benefit populations impacted by disparities in healthcare.
October 20, 2022
Exact Sciences awards $525K in grants to improve CRC screening
Exact's Funding Opportunities for CRC Screening Uptake Strategies (FOCUS) program provided the grant funding. Awardees will use the funds to implement evidence-based and informed intervention strategies proven to increase colorectal cancer screening rates, the firm said.
September 21, 2022
USPSTF: more evidence needed on diabetes screening
The Task Force concluded that more research is needed to recommend for or against screening children and adolescents without signs or symptoms.
September 12, 2022
Week in Review: Roche’s new MDx system, HIV world market, cervical cancer testing disparities, and more
Dear LabPulse.com member,
August 24, 2022
Quest Diagnostics launches HCV obstetrics panel
The company developed the new test panel to include HCV antibody testing with a reflex to quantitative real-time PCR testing, in response to findings from a health trends study published in Obstetrics & Gynecology.
August 16, 2022
Bionano touts study on optical genome mapping
The results were published July 21 in the Journal of Neurology.
August 11, 2022
Page 1 of 8
Next Page
